Hemolytics

Switzerland
Grono, Grisons, Switzerland

Company profile

Hemolytics company profile

Hemolytics is a MedTech company that develops a chemical amplification method for ultrasensitive detection of malaria using inexpensive reagents. It may be used as a point of care diagnostic test kit with a sensitivity 10-fold superior to that of the most sophisticated currently available malaria rapid diagnostic tests (MRDT).

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $9,949 / 2018-10-30
Investors
1
Lead investors
1

Founders and investors

Lead investors

Venture Kick

Investors

Venture Kick